Cyclooxygenase‐2 (COX‐2) inhibition for prostate cancer chemoprevention: double‐blind randomised study of pre‐prostatectomy celecoxib or placebo

Abstract

To evaluate the biological effects of selective cyclooxygenase‐2 inhibition on prostate tissue in patients undergoing radical prostatectomy (RP).

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Aug 23, 2016
• Source ID: 10.1111/bju.13612

Entities

People

• Harman S. Sekhon
• Jason F. Flamiatos
• Julie N. Graff
• Kristine M. Eilers
• Mark Garzotto
• Tomasz M Beer
• Wei Tian

Organizations

• Oregon Health & Science University
• Pfizer
• United States Department of Defense
• University of Ottawa

Tags

Fields of Study

• Medicine

Readers

• Molecular and genetic basis of cancer.
• Oncology
• Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

• Biotechnology
• Biotechnology - Cancer Biotech